e-learning
resources
London 2016
Sunday, 04.09.2016
Mesothelioma and pleural disease: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A conditional mouse model of malignant pleural mesothelioma
Anthi Krontira (Patras, Greece), Anthi Krontira, Malamati Vreka, Marianthi Iliopoulou, Ioannis Lilis, Theodora Agalioti, Nicoleta Spiropoulou, Georgia Giotopoulou, Yuval Rinkevich, Magda Spella, Georgios Stathopoulos, Antonia Marazioti
Source:
International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Session:
Mesothelioma and pleural disease: from the bench to the bedside
Session type:
Oral Presentation
Number:
497
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anthi Krontira (Patras, Greece), Anthi Krontira, Malamati Vreka, Marianthi Iliopoulou, Ioannis Lilis, Theodora Agalioti, Nicoleta Spiropoulou, Georgia Giotopoulou, Yuval Rinkevich, Magda Spella, Georgios Stathopoulos, Antonia Marazioti. A conditional mouse model of malignant pleural mesothelioma. Eur Respir J 2016; 48: Suppl. 60, 497
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015
Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012
Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Effect of smoking on experimental malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Management of malignant mesothelioma
Source: ERS Skills Course 2018 - Practical Pleural Skills
Year: 2018
Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Volume quantification of malignant pleural mesothelioma
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma
Source: Eur Respir J 2005; 26: Suppl. 49, 74s
Year: 2005
Management of malignant pleural mesothelioma in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017
Tumours of the pleura - Mesothelioma
Source: Respipedia Article
Year: 2017
A conditional contribution of mast cells to malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept